Skip to main content
. 2019 Oct 24;10:2511. doi: 10.3389/fimmu.2019.02511

Figure 3.

Figure 3

Kaplan-Meier analyses for percentage graft failure (A) and survival (B) according to no sC5b-9/no properdin, sC5b-9/no properdin, no sC5b-9/properdin, sC5b-9/properdin. Log-rank tests showed that the prevalence of graft failure and survival were significantly higher in the patients with urinary properdin and sC5b-9. Associations between survival and urinary properdin and sC5b-9 did not remain significant after adjustment for potential confounders.